As part of the deal, the companies will engage in joint testing, verification and validation to support interoperability between the systems, Munich-based Brainlab said. Brainlab added that it has worked with Varian since 1996, and that its new agreement is a “natural progression of the relationship between the two companies.”
“We are excited about growing the install base of around 1,000 ExacTrac systems for IGRT. After working with Varian for 20 years this step will intensify our collaboration, resulting in enhanced safety and interoperability for the benefit of patients,” Brainlab prez & CEO Stefan Vilsmeier said in a press release.
Brainlab’s ExacTrac is an in-room based X-ray positioning and monitoring system designed to detect intra-fractional motion of internal anatomy during treatment delivery, the company said.
“We look forward to continuing our collaboration with Brainlab by offering our customers more options for patient positioning and ensuring interoperability between ExacTrac and Edge systems,” Varian oncology systems biz prez Kolleen Kennedy said in a prepared statement.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.